Navigation Links
Women’s Fashion Sense Linked to Her Ovulatio

A woman’s dress sense may be governed by her ovaries according to a new report.The study conducted by UCLA and the University of Wisconsin-Eau Claire// showed that women put more time and effort into their appearance when they're ovulating.

Not only does a woman’s clothes and makeup affected at that time of the month a woman’s strength, appetite and attitudes toward men and each other alter as well.

Study's lead author, UCLA professor Martie Haselton, giving details about her study said, "What we did was photograph the women on a high fertility day and a low fertility day, and we showed those photographs to a separate set of judges, and we asked them, 'In which photo is the woman trying to be more attractive?'"

The judges picked a woman's high fertility photograph 60 percent of the time — a rate much higher than random chance. Haselton said, "For the women who were actually ovulating on the day of their period, it was more than 80 percent for those photos."

Her study has put to rest a long time myth that women hid all signs of ovulation, even from themselves and their mates. Haselton showed that many signs do exist, although subtle.

Haselton said, "Women experience a decrease in appetite near ovulation, even though there's an increased caloric need. And that's not just compared to when they are PMSing." Growing evidences have shown women are stronger when they're most fertile. She said, "There's one study that showed that women's hand strength increased during ovulation."

In fact women may even be more tempted to cheat when they're ovulating than at other times of the month. Their preferences for types of men can also change.

Haselton added, "They look more for facial masculinity and male scents — the body scents that may be associated with greater testosterone. They tend to go for the softer side, kind and caring, having sweet faces."

Their interactions with other women are also aff
'"/>




Page: 1 2

Related medicine news :

1. Women’s Heart Conditions Are Often Ignore
2. Soy Protein Not Only For Women’s Health But For Men’s To
3. Delhi To Host International Women’s Congress From Nov 2
4. First Exclusive Women’s Clinic Launched in Chennai By Apollo Hospita
5. Women’s Day of Festivities during Attukal Pongala, Tomorro
6. Private Medical Insurers Rise To Women’s Requirement of ‘Hercepti’
7. Micro vascular Disease Enabled with a Superior Test, Courtesy: Women’s Heart Progra
8. Bacterium Overtook Patients At Brisbane Women’s Hospita
9. Pelvic Exams without Stirrups May Improve Women’s Healt
10. Outwardly Expressed Anger Affects Some Women’s Heart Arterie
11. Extra Cortisol Protects Women’s Mood Under Stres
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Women Fashion Sense Linked Her Ovulatio

(Date:10/13/2008)...ir levels were lower than Alzheimer,s patients, he...althDay News) -- Parkinson,s disease patients are ...ients to have vitamin D deficiency, say researcher...Atlanta. , They compared vitamin D levels in 10...nd 99 healthy people matched for age and other fac...
(Date:10/13/2008)...., Oct. 13, 2008 /PRNewswire/ -- The AMERIGROUP Fo... of the School for Children with,Hidden Intelligen...,training program., SCHI is a state-approved, pri...ndicapped, underprivileged children with special n... and alleviate the suffering of the,most vulnerabl...
(Date:10/13/2008)...perium(TM) Market Leading Content Rights Managemen...g the Loop on Their Content Spend, WEST CHESTER, ...ed,today that a leading global pharmaceutical manu...logy to become the primary platform for the,secure...d reporting,analytics for their new product video ...
(Date:10/13/2008)...s a significant problem in daily life, survey show.../ -- Approximately,three-quarters of people living...roblem in daily life, according to a National Psor... survey of 426 individuals with psoriasis and psor...nfluences their daily lives, shapes their,feelings...
Breaking Medicine News(10 mins):Health News:Parkinson's Patients More Prone to Vitamin D Deficiency 2Health News:AMERIGROUP Foundation Supports the School for Children with Hidden Intelligence 2Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Psoriasis Foundation Releases 2008 Study Results 2
...or for cardiovascular diseases.A potbelly indicate...f the rest of the body is skinny as a beanpole. T...isk is the relationship of waist size to the hips,...icts an increased risk of heart attack. The study ...
...immings of cloned pig’s bacon, a jar of cloned cow...er; ‘Frankenstein foods’, as some// refer to it. ...stration (FDA) of US is getting ready to pass a bi...animal products. “We based our decision on lookin...
...'s 2002 Gay Pride, San Francisco Department of Pub...arize syphilis testing. In the above said campaig...roduced to Gayville, encouraging the many hundreds...hered there to get themselves tested for the big-S...
... a weight reduction pill, which works better and f... risk of heart disease, diabetes and cancer. Exis...ve to 10 percent when taken for a year. But men a...e new pill developed by Californian biopharmaceuti...
Other Medicine News:Health News:Pot Belly Is A Better Risk Predictor Of Heart Attack Than BMI 2Health News:Clones On the Menu 2
(Date:10/10/2008)...INGTON and MENLO PARK, Calif., Oct. 10 /PRNewswire...announced that it plans to present,long-term follo...rials next,week at the Cardiovascular Research Fou...diovascular Therapeutics (TCT) meeting in Washingt... studies designed to investigate,the safety and ef...
(Date:10/10/2008)...SANTON, Calif., Oct. 10 /- TriReme Me...authorized to affix the CE (Conformite,Europeenne)...M) Coronary,Stent System, a unique main vessel ste...ronary bifurcations., Representing the next gener...tem has potential use in a quarter of the 2.2 mill...
(Date:10/9/2008)...pps Translational Science Institute, Navigenics, A...lth study, SAN DIEGO, Oct. 9 /- A co...eaders have joined forces in a first-of-its-kind,r...ersonal genetic testing,on people who choose to re...risk for developing certain diseases., Sponsored ...
(Date:10/8/2008)...ona Heart Institute Pioneers Research That May Off...ct. 8 /- Nationally, over 3,000 peopl...ease on life. Sadly, only half,of those will recei...na,Heart Institute (AHI) is paving the way for how..., To view the Multimedia News Release, go to:, ht...
Breaking Medicine Technology:XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Patient Safety Technologies Closes on 242 325 Million in Equity Financing 25845 1Patient Safety Technologies Closes on 242 325 Million in Equity Financing 25845 2Replidyne Announces Restructuring of Operations 25843 1Replidyne Announces Restructuring of Operations 25843 2VaxGen Provides Financial Update Following the Filing of Its 10 Q for Second Quarter With SEC 3B Results Include 248 5 Million Charge in Respect of M 25840 1VaxGen Provides Financial Update Following the Filing of Its 10 Q for Second Quarter With SEC 3B Results Include 248 5 Million Charge in Respect of M 25840 2VaxGen Provides Financial Update Following the Filing of Its 10 Q for Second Quarter With SEC 3B Results Include 248 5 Million Charge in Respect of M 25840 3New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 1New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 2New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 3New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 4New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 5New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 6
...23, 2007 /PRNewswire-FirstCall/ -- Shire plc,annou...l system),the first and only non-oral medication ...ctivity Disorder (ADHD) in children aged 6,to 12 y...control,and tolerability, according to results of ...can Psychiatric Association (APA),annual meeting i...
...--(BUSINESS WIRE)--May 23, 2007 - Synta,Pharmaceut...mpany,focused on discovering, developing, and comm...edical conditions, today announced,that survival a...trial in metastatic melanoma of the Company,s lead...ted at the annual meeting of the,American Society ...
Other Medicine Technology:12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 212-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 312-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 412-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 512-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 612-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 712-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 812-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 9Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 2Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 3
... Volk Area Centralis® is excellent for critica...ization and changes from macular degeneration, ret...proliferative diabetic retinopathy and other retin...nt of these conditions providing excellent magnifi...
... original 130° QuadrAspheric lens has grown in...preferred wide field fundus laser lens. Its sleek ...age over competitive wide field lenses for periphe...ease of use. This lens is excellent for small pupi...
The Digital Wide Field Lens combines exceptional wide field views and high magnification. The enhanced double aspheric design and multi-layer coating provide high resolution stereo views of the retin
...ks Super VitreoFundus® provides ultra wide-fie... quick and comprehensive fundus exams at the slit ... a wide field of view through small pupils without...all pupil lenses. Delivering an incredible 124°...
Medicine Products: